Finance

Lists
BIOV:CNSX
Biovaxys Technology Corp
0,070 CA$
0,00%
(0,00) 1D
5 მაი, 15:55:53 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Mkt. cap
3,09 მლნ.
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CA$
52-wk low
0,03 CA$
Mkt. cap
3,09 მლნ.
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CA$
52-wk low
0,03 CA$
News stories
From web sources and news partners
About Biovaxys Technology Corp
CEO-
Employees-
Founded-
Headquartersტორონტო, ონტარიო, კანადა
SectorPharmaceutical industry
Websitebiovaxys.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ოქტ. 2024
იან. 2025
აპრ. 2025
ივლ. 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,50 ათ.
32,95 ათ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,20 მლნ.
1,03 მლნ.
1,08 მლნ.
859,08 ათ.
Operating expense
1,49 მლნ.
1,14 მლნ.
1,22 მლნ.
859,08 ათ.
Total operating expenses
1,49 მლნ.
1,14 მლნ.
1,22 მლნ.
859,08 ათ.
Operating income
-1,49 მლნ.
-1,14 მლნ.
-1,22 მლნ.
-859,08 ათ.
Other non operating income
-8,90 ათ.
-68,18 ათ.
-67,98 ათ.
-50,97 ათ.
EBT including unusual items
-2,74 მლნ.
-1,07 მლნ.
-1,32 მლნ.
-910,06 ათ.
EBT excluding unusual items
-1,50 მლნ.
-1,25 მლნ.
-1,30 მლნ.
-910,06 ათ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,74 მლნ.
-1,07 მლნ.
-1,32 მლნ.
-910,06 ათ.
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები